Evidence map›Paper›PMID 34759799›Full record

ReviewFrontiers in molecular neuroscience2021

TDP-43 and ER Stress in Neurodegeneration: Friends or Foes?

Lorena de Mena, Joshua Lopez-Scarim, Diego E Rincon-Limas

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in molecular neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. TDP-43: [GU]-ardian of the transcriptome.Molecular neurodegeneration · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. NovelOpen biology · 2024
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Lorena de MenaDepartment of Neurology, McKnight Brain Institute, and Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, United States.
Joshua Lopez-ScarimDepartment of Neurology, McKnight Brain Institute, and Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, United States.
Diego E Rincon-LimasDepartment of Neurology, McKnight Brain Institute, and Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, United States.
University of Florida · US

Funding

Deconstructing and challenging TDP-43 proteinopathies: from FTLD/ALS to Alzheimer's diseaseR01AG059871 · NIA · UNIVERSITY OF FLORIDA · PI RINCON-LIMAS, DIEGO E · 2018 to 2022
$1.9M
GatorSTAR: A New MARC U*STAR Program at the University of FloridaT34GM118272 · NIGMS · UNIVERSITY OF FLORIDA · PI JULIAN, DAVID · 2016 to 2021
$1.5M
MARC at the University of FloridaT34GM145447 · NIGMS · UNIVERSITY OF FLORIDA · PI JULIAN, DAVID, MARTINS, TALLINE · 2022 to 2024
$845k
NIA NIH HHS R01 AG059871NIGMS NIH HHS T34 GM118272NIGMS NIH HHS T34 GM145447
6 · The paper itself

Abstract

Nuclear depletion, abnormal modification, and cytoplasmic aggregation of TAR DNA-binding protein 43 (TDP-43) are linked to a group of fatal neurodegenerative diseases called TDP-43 proteinopathies, which include amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Although our understanding of the physiological function of TDP-43 is rapidly advancing, the molecular mechanisms associated with its pathogenesis remain poorly understood. Accumulating evidence suggests that endoplasmic reticulum (ER) stress and the unfolded protein response (UPR) are important players in TDP-43 pathology. However, while neurons derived from autopsied ALS and FTLD patients revealed TDP-43 deposits in the ER and displayed UPR activation, data originated from

Indexed as

ER stressneurodegenerationpERKproteinopathiesTDP-43UPRXBP1

Identifiers

PMID34759799
PMCPMC8573113
OpenAlexW3210025550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.